Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Early diagnosis and multidisciplinary care, including orthopedic surgery, can prevent long-term disability in IFAP syndrome.

Systemic steroids effectively treated severe nail issues in a card illusionist with alopecia areata.

Educating patients on phototrichogram increased satisfaction in androgenetic alopecia treatment.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

Nail changes in alopecia areata are common and may indicate severity and genetic risk.

Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Platelet-Rich Plasma treatment has limited and temporary effects on severe Alopecia Areata and does not prevent relapses.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Rituximab can cause skin issues, but baricitinib may help improve them.

The combination of calcipotriol and PRP is the most effective treatment for alopecia areata.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

Proper diet, monitoring, and protein supplements are crucial after bariatric surgery to prevent severe malnutrition.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Upadacitinib improved multiple immune-related conditions in one patient.